Skip to content

Clinical trials

Observational Diabetes Mellitus, Type 2 trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Observational Country / region: Singapore Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20082
20091
20111
20141
20171
20201
20211
20222
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting1
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S4
AstraZeneca2
Singapore General Hospital2
Bayer1
Changi General Hospital1
Merck KGaA, Darmstadt, Germany1
Nanyang Technological University1
Pfizer1
Singapore Chung Hwa Medical Institution1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 214
Diabetes Mellitus6
Diabetes Mellitus, Type 12
Diabetes Complications1
Diabetic Foot1
Dyslipidemias1
Foot Ulcer1
Glucose Intolerance1
Hip Fractures1
Hyperglycemia1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.